Cleveland BioLabs, Inc.

Sheila Greco Associates, May 2011, Pages: 1

Cleveland BioLabs, Inc. is a drug discovery and development company leveraging its proprietary mechanistic discoveries about programmed cell death to treat cancer and protect normal tissues from exposure to radiation and other stresses. CBLI has strategic

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought

• Biodefense Industry - Market to Benefit from Federal Funding such as the BIO EDEP Fund to Support Security Plans
• The Future of the Biodefense Industry: Regulation, Funding Opportunities & Company Profiles
• U.S. DoD 2012 Budget
• Military Microgrids Market Potential
• Commercial Unmanned Aerial Systems (UAS): Market Shares, Strategies, and Forecasts, Worldwide, 2012 to 2018
• 2012 America's Neighborhoods-Zip Code 44130 for Cleveland, OH report
• Pathology at a Glance. At a Glance
• Understanding Educational Statistics Using Microsoft Excel and SPSS
• Journal of Drug Education
• U.S. High Content Screening Markets